Overview
Attorney Marylana Saadeh Helou focuses her practice on advising academic medical centers, hospitals, universities, pharmaceutical and medical device companies, digital health companies, and other health care technology companies and research organizations on issues related to human subjects research and data privacy.
Marylana’s experience includes the following:
- Assisting clients in navigating requirements under the Common Rule, HIPAA, and other federal, state, and international human subject protection requirements and data protection and privacy laws, including the GDPR
- Counseling on the structure of research agreements for multi-site global industry-sponsored clinical trials, investigator-initiated studies, and strategic research collaborations, and assisting clients in the drafting and negotiation of such agreements and related informed consent forms and authorizations
- Advising clients on complex and evolving regulatory issues and considerations related to structuring decentralized clinical trials, mobile app/device research, internet research, and repositories for health data, genomic, and biospecimen research, including navigating secondary uses of stored materials
- Advising on FDA requirements for clinical investigations, treatment with investigational products under FDA’s expanded access program and “Right to Try” laws, and FDA Part 11
- Counseling clients on issues related to research noncompliance and misconduct proceedings
- Counseling on matters related to individual and institutional conflicts of interest, and assisting clients in reviewing and updating their policies and procedures to appropriately identify and manage such conflicts
- Advising on compliance with federal grant standards and efforts to address undue foreign influence in federally-funded research
Before joining Epstein Becker Green, Marylana was an attorney in the Health Care & Life Sciences Group of a New England regional law firm. While attending law school, she interned at the Office of the General Counsel for a not-for-profit, integrated health care system in Boston; the Massachusetts U.S. Attorney's Office as part of the Health Care Fraud Unit; and a public interest law firm whose mission is to provide pro bono legal representation. She also served as a judicial intern for the Honorable Magistrate Judge Judith G. Dein of the U.S. District Court for the District of Massachusetts.
Prior to entering law school, Marylana was a research assistant at Boston University School of Medicine's Obesity and Diabetes Research Center, where she conducted NIH-funded research to determine how fuels generate signals to modulate insulin secretion from pancreatic cells. Her work is published and referenced in several scientific journals. Marylana has been selected by peers for inclusion on the Massachusetts Rising Stars list (2013-2023) in the area of Health Care and was recognized by the 2021 edition of The Best Lawyers in America©: “Ones to Watch,” in the category of Health Care Law. She served as a community member of the Brigham and Women’s Hospital Institutional Review Board from 2014 to 2020.
Read less
Focus Areas
Services
- Academic and Clinical Research
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Industry Research and Clinical Trials
- Life Sciences
- Life Sciences Due Diligence
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Regulatory Strategy, Product Development, and Product Approvals
Industries
Trending Issues
Experience
Recognition
- The Best Lawyers in America, “Ones to Watch,” Health Care Law (2022 to 2025)
- Massachusetts Rising Stars, Health Care (2013 to 2024)
Credentials
Education
- Boston University School of Law (J.D., 2013)
- American University of Beirut (B.S., 2007)
Bar Admissions
- Massachusetts
Professional & Community Involvement
- American Health Lawyers Association
- Boston Bar Association
- Brigham and Women's Hospital Institutional Review Board, Community Member (2014 – 2020), Community Member
Languages
- Arabic
Media
Events
Upcoming Events
Past Events
Insights
Insights
- BlogsThe NIH IDC – Where Are We Now6 minute read
- Media CoverageMarylana Saadeh Helou Quoted in “FDA Offers Road Map for Remote Trials, but Questions Linger”2 minute read
- Firm Announcements
Four Epstein Becker Green Attorneys Named to the 2024 Massachusetts Super Lawyers and Rising Stars Lists
8 minute read - Media CoverageBBA Spotlight Series: Get to Know Emerging Leaders in Boston Law–Marylana Saadeh Helou8 minute read
- PublicationsSumming Up the FDA's Long-Anticipated Draft Guidance on Diversity Action Plans3 minute read
- Firm Announcements
Epstein Becker Green Attorneys Honored for Excellence in the Legal Profession by Best Lawyers 2025
14 minute read - PublicationsFDA Issues Long-Anticipated Draft Guidance on Diversity Action Plans16 minute read
- Media CoverageLaw360 Names the Twelve Epstein Becker Green Attorneys Who Moved Up the Ranks in Q1 20242 minute read
- PublicationsFDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research ...9 minute read
- Media Coverage
As Featured in Law360: Epstein Becker Promotions Inch Up with 12 Members Named
2 minute read - Firm AnnouncementsEpstein Becker Green Announces 2024 Promotions6 minute read
- Firm Announcements
Three Epstein Becker Green Attorneys Named to the 2023 Massachusetts Super Lawyers and Rising Stars Lists
13 minute read - PublicationsORI Releases Notice of Proposed Rulemaking to Update 2005 Public Health Service Policies on Research Misconduct ...7 minute read
- BlogsFDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors4 minute read
- Firm Announcements
Epstein Becker Green Attorneys Recognized by 2024 Best Lawyers for Excellence in the Legal Profession
12 minute read - PublicationsFDA Issues Draft Recommendations for Implementing Decentralized Clinical Trials20 minute read
- PublicationsReminder of March 31 “Right to Try” Reporting Deadline8 minute read
- Firm Announcements
Three Epstein Becker Green Attorneys Named to the 2022 Connecticut and Massachusetts Super Lawyers and Rising Stars Lists ...
8 minute read - PublicationsOHRP Draft Guidance on the Use of Single IRBs: Reminder to Comment by August 308 minute read
- Firm Announcements
Epstein Becker Green Attorneys Recognized by 2023 Best Lawyers for Excellence in the Legal Profession
11 minute read - Blogs
Biden Administration Seeks to Clarify Patient Privacy Protections Post-Dobbs, Though Questions Remain
11 minute read - PublicationsOSTP Releases Highly Anticipated Guidance on National Security Strategy for Federally Funded Research6 minute read
- Firm Announcements
Four Epstein Becker Green Attorneys Named to 2021 Connecticut and Massachusetts Super Lawyers and Rising Stars Lists ...
9 minute read - Firm AnnouncementsThirty-Five Epstein Becker Green Attorneys Recognized as “Ones to Watch” by The Best Lawyers in America 2022 ...5 minute read
- PublicationsRansomware: A Guide to Practical, Regulatory, and Reputational Risk Management16 minute read
- Firm Announcements
David S. Poppick, Peter M. Stein Named to 2020 Connecticut Super Lawyers List, Marylana Saadeh Helou Named to 2020
7 minute read - PublicationsEpstein Becker Green’s Boston Health Care and Life Sciences Practice Featured in “Hire Up: This Week’s Lateral ...2 minute read
- Firm AnnouncementsEpstein Becker Green Adds Group of Health Care & Life Sciences Attorneys in Boston6 minute read